If the key regulators in autophagy can be targeted to activate and increase autophagic degradation, while reducing the accumulation of HIF-2α in NPC caused by pVHL inactivation, it can be used as a novel NPC treatment approach. This evidence concerns the gene EPAS1 and nasopharyngeal carcinoma.